Survey issued by TraceLink and IDC cites various challenges for pharma shippers amid COVID-19
November 18, 2020
While there have been some positive developments, in recent days regarding new vaccines for the ongoing COVID-19 pandemic, a white paper issued today sponsored by North Reading, Mass.-based TraceLink, a provider of supply chain visibility platform services for the life sciences supply chain, in collaboration with research firm IDC, highlighted the myriad challenges that the pandemic has wrought upon pharmaceutical shippers.
